Table 3 Top areas of consensus and dissensus among panelists
Top consensus topics | Top dissensus topics |
|---|---|
Section 1 – Patient population | |
• Generic LAI use • Appropriateness for FEP and EP patients | • Potential exclusions |
Section 2 – Dosage, management & adverse events | |
• Adverse event management |  |
Section 3 – Functional recovery domains & assessment | |
• Long-term treatment goals • LAI links to functional recovery • Functional recovery domain |  |